"We designed the ScanScope XT system for high-throughput environments, such as busy pathology labs and biopharma organizations, which need fully automated, reliable, and ultra-fast scanning to digitize large volumes of slides," said Dirk Soenksen, CEO of Aperio. "The XT system is based on Aperio's trusted and patented line-scanning technology, providing digital slides with consistently superior image quality."
The ScanScope XT allows pathologists to load and scan up to 120 glass slides with the touch of a button, automating what can be a time-consuming process. Supported by Aperio's web-based Spectrum(TM) digital pathology information management software, pathologists using the XT system are also able to manage and analyze vast amounts of digital slides and other data in project-specific, context-based configurations. For biopharma, this means speeding the drug discovery process and providing valuable project histories and archival abilities. For busy pathology labs, volumes of digital slides can be posted for educational and research purposes.
With its automated, reliable, ultra-fast, and high-capacity scanning capabilities, the ScanScope XT is Aperio's most advanced scanning system. When compared to its predecessor, the ScanScope T2, it also boasts a streamlined design, significantly smaller footprint, accelerated JPEG2000 compression for faster and higher resolution scanning, and a readily accessible magnification changer for instantly switching between 20x and 40x.
The ScanScope XT will also be exhibited in September at CAP '06, The Pathologists Meeting, in San Diego, and is available for immediate delivery.
About Aperio Technologies, Inc.
Aperio is digitizing pathology. We provide systems and services for digital pathology, which is a digital environment for the management and interpretation of pathology information that originates with a digital slide. Aperio's award-winning ScanScope slide scanning systems and Spectrum digital pathology information management software improve the efficiency and quality of pathology services for pathologists and other professionals. Applications include education, remote viewing, archival and retrieval, basic research, and image analysis. While Aperio is pursuing regulatory clearance to address the clinical market, Aperio's products have not yet been cleared or approved by the FDA. For more information and to view a gallery of digital slides created by ScanScope Systems, please visit www.aperio.com.